REFERENCES
- Berger , V. W. , Ivanova , A. , Knoll , M. D. ( 2003 ). Minimizing predictability while retaining balance through the use of less restrictive randomization procedures . Stat. Med. 22 : 3017 – 3028 .
- Echt , D. S. , Liebson , P. R. , Mitchell , L. B. , Peters , R. W. , Obias-Manno , D. , Barker , A. H. , Arensberg , D. , Baker , A. , Friedman , L. , Greene , H. L. , Huther , M. L. , Richardson , M. W. , and the CAST investigators . ( 1991 ). Mortality and morbidity in patients receiving encainide, flrcaonide, or placebo. The Cardiac Arrhytmia Suppression Trial . N. Engl. J. Med. 324 : 781 – 788 .
- Ellenberg , S. S. , Fleming , T. R. , DeMets , D. L. ( 2002 ). Data Monitoring Committees in Clinical Trials. A Practical Perspective . Chichester : John Wiley & Sons .
- Gould , A. L. , Shih , W. J. ( 1992 ). Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance . Commun. Statist. Theory Meth. 21 ( 10 ): 2833 – 2853 .
- ICH . ( 1998 ). Topic E9 (Step 4, Consensus guideline, 5.2.98). Statistical Principles for Clinical Trials. htpp://www.fda.gov/cder/guidance/index.htm
- Kalish , L. A. , Begg , C. B. ( 1985 ). Treatment allocation methods in clinical trials: A review . Stat. Med. 4 : 129 – 144 .
- McEntegart , D. J. (2003). The pursuit of balance using stratified and dynamic randomization techniques: An overview. Drug Info. J. 37:293–308. [CSA]
- Shih , W. J. ( 1992 ). Sample size reestimation in clinical trials . In: Peace , K. , ed. Biopharmaceutical Sequential Statistical Applications . New York : Marcel Dekker , pp. 285 – 301 .
- Shih , W. J. ( 1993 ). Sample size reestimation for triple blind clinical trials . Drug Info. J. 27 : 761 – 764 .